Cian Healthcare

Cian_Healthcare03 May 2024

Pharmaceuticals

₹

+1.07 (+4.96%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Cian Healthcare

Cian Healthcare

Pharmaceuticals

Cian_Healthcare03 May 2024

₹

+1.07 (+4.96%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date
05-Feb-2024	BC	Source: BSE Announcement PDF	05-Feb-2024
18-Jan-2024	BC	Intimation of Appointment of Mr. Prateek Shriprakash Kulkarni as an Independent Director of company w.e.f. 17th January, 2024	17-Jan-2024
18-Jan-2024	BC	Intimation of Appointment of Mr. Prateek Shriprakash Kulkarni as an Independent Director of company w.e.f. 17th January, 2024	17-Jan-2024
05-Dec-2023	BC	Notice of Postal Ballot and Event Calendar Submission of Newspaper Advertisement about Notice Postal Ballot through remote e-Voting. (As Per BSE Announcement Dated on 06/12/2023) Scrutinizer	04-Jan-2024
30-Dec-2023	BC	Revised Outcome of Board meeting for migration of Company''s present listing of equity shares from SME Platform of BSE Limited to Main Board of NSE Platform. Filing revised Outcome as in earlier outc	30-Dec-2023

No Rights has been declared by Cian_Healthcare

Book Closure

Record Date	Split Date	Purpose
05-Feb-2024	01 Jan'1900	Source: BSE Announcement PDF
17-Jan-2024	-	Intimation of Appointment of Mr. Prateek Shriprakash Kulkarni as an Independent Director of company w.e.f. 17th January, 2024
17-Jan-2024	-	Intimation of Appointment of Mr. Prateek Shriprakash Kulkarni as an Independent Director of company w.e.f. 17th January, 2024
04-Jan-2024	01 Jan'1900	Notice of Postal Ballot and Event Calendar Submission of Newspaper Advertisement about Notice Postal Ballot through remote e-Voting. (As Per BSE Announcement Dated on 06/12/2023) Scrutinizer
30-Dec-2023	-	Revised Outcome of Board meeting for migration of Company''s present listing of equity shares from SME Platform of BSE Limited to Main Board of NSE Platform. Filing revised Outcome as in earlier outc

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Cian Healthcare Ltd ₹22.63(+1.07/4.96%)	22.63	+1.07	56.57	-38.29	53.88	0.92
Astrazeneca Pharma India Ltd ₹5,424.45(+90.60/1.70%)	5,424.45	+90.60	13,561.13	71.45	85.02	20.71
Bliss GVS Pharma Ltd ₹119.10(-10.10/-7.82%)	119.10	-10.10	1,246.87	56.07	18.27	1.28
Cipla Ltd ₹1,424.75(+5.20/0.37%)	1,424.75	+5.20	115,033.60	54.70	34.98	4.44
Amrutanjan Health Care Ltd ₹775.50(-11.10/-1.41%)	775.50	-11.10	2,242.02	27.78	50.95	8.56
Abbott India Ltd ₹26,144.45(-459.90/-1.73%)	26,144.45	-459.90	55,556.96	15.92	48.50	17.87

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	25.00	25.00	23.36	23.36	17.14	1.40
Reserves Total	36.43	35.35	36.51	36.19	4.56	16.34
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	61.43	60.35	59.87	59.55	21.70	17.74
Secured Loans	39.04	38.66	44.20	45.27	24.08	43.53
Unsecured Loans	3.68	4.42	5.10	5.95	24.58	6.88
Total Debt	42.72	43.08	49.30	51.22	48.66	50.41
Total Liabilities	104.15	103.43	109.17	110.77	70.36	68.15
APPLICATION OF FUNDS :
Gross Block	48.27	48.03	31.37	30.36	31.21	25.39
Less : Accumulated Depreciation	18.85	15.20	12.64	9.59	7.73	5.39
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	29.42	32.83	18.73	20.77	23.48	20.00
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	13.89	13.00	25.71	24.80	6.37	6.56
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	7.09	7.09	7.09	7.09	0.00	0.00
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	34.81	34.02	25.71	19.72	15.95	15.83
Sundry Debtors	23.54	18.26	18.54	19.95	22.22	25.57
Cash and Bank	1.13	1.22	2.21	3.02	2.33	0.59
Loans and Advances	8.77	15.29	11.22	8.87	14.97	1.76
Total Current Assets	68.24	68.79	57.67	51.55	55.47	43.75
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	27.64	33.45	21.47	20.58	19.39	6.45
Provisions	0.54	0.33	0.66	0.40	0.40	0.74
Total Current Liabilities	28.18	33.78	22.13	20.98	19.79	7.19
Net Current Assets	40.06	35.02	35.54	30.57	35.67	36.55
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Liability	1.10	1.18	1.28	1.35	1.35	1.23
Net Deferred Tax	-1.10	-1.18	-1.28	-1.35	-1.35	-1.23
Total Assets	89.35	86.75	85.79	81.89	64.17	61.88
Contingent Liabilities	0.00	0.00	0.00	0.00	0.00	0.00

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash and Cash Equivalents at Beginning of the year	1.22	2.21	3.02	2.33	0.59
Net Cash from Operating Activities	2.15	5.51	5.46	-9.24	12.80
Net Cash Used In Investing Activities	-1.08	-3.85	-1.20	-25.16	-8.32
Net Cash Used In Financing Activities	-1.17	-2.65	-5.07	35.09	-2.74
Net Inc./Dec In Cash And Cash Equivalents	-0.10	-0.99	-0.81	0.69	1.74
Cash And Cash Equivalents At End Of The Year	1.13	1.22	2.21	3.02	2.33

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

27.10%

FII Shareholding

0.00%

DII Shareholding

0.00%

Public Shareholding

72.90%

**Promoter pledged shareholding 27.10%

About Cian Healthcare Ltd

Cian Healthcare Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 56.57 crores. It has reported a sales of Rs. 0 crores and a net profit of Rs. 0 crores for the quarter ended December 2018. The company management includes , Suraj Zanwar,Munjaji Purbhaji Dhumal,Swati Maheshwari,Paresh Arun Shah,Sunil Kumar (Cian Healthcare Ltd) among others.

Chairman

Registered office

Milkat No 3339 BNo 1 Phursungi,From Southside CS NO 227/2,Pune,Maharashtra,412308

FAX :

Background

Incorporation Year2003

Face Value₹10

Market Lot2000

How to buy Cian Healthcare shares on nse?

To buy Cian Healthcare shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Cian Healthcare share price today?

The Cian Healthcare shares price on nse is Rs.22.63 today.

What is the market cap of Cian Healthcare shares on BSE ?

The company has a market capitalization of Rs.56.57Cr

What is the PE & PB ratio of Cian Healthcare shares ?

PE is 53.88 and PB is 0.92

What is the 52 Week High and Low of Cian Healthcare shares?

Cian Healthcare stock price high: Rs.41.1 Cian Healthcare stock price low: Rs.16.05